BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1036990)

  • 41. HLA-BW35 and subacute de Quervain's thyroiditis [proceedings].
    Buc M; Nyulassy S; Hnilica P; Stefanovic J
    Diabete Metab; 1976 Sep; 2(3):163. PubMed ID: 1010141
    [No Abstract]   [Full Text] [Related]  

  • 42. Further population studies of HLA-D alleles in the German population [proceedings].
    Grosse-Wilde H; Netzel B; Ruppelt W; Albert ED; Bertrams J; Brehm G; Ewald R; Hauptmann G; Johannsen R; Kuntz B; Lenhard V; Mayer S; Reis HE; Rittner C; Scholz S; Tongio MM
    Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):277-80. PubMed ID: 1007378
    [No Abstract]   [Full Text] [Related]  

  • 43. HLA-B/D recombination frequency and MLC studies in recombinant families [proceedings].
    Netzel B; Grosse-Wilde H; Suciu-Foca N; Rittner C; Scholz S; Albert ED
    Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):289-92. PubMed ID: 137597
    [No Abstract]   [Full Text] [Related]  

  • 44. [Thyroid neoplasms and HL-A system].
    Májský A; Feix C; Nĕmec J
    Z Gesamte Inn Med; 1978 Nov; 33(21):797-8. PubMed ID: 735255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The distribution of HLA antigens in patients with duodenal ulcer].
    Heschl R; Tilz GP
    Acta Med Austriaca; 1976; 3(3):80-2. PubMed ID: 1002457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HLA in maturity-onset diabetes [proceedings].
    Sakurami T; Nabeya N; Nagaoka K; Kurahashi H; Kuno S; Nose Y; Sumitomo K; Tsuji K
    Diabete Metab; 1976 Sep; 2(3):159. PubMed ID: 1022230
    [No Abstract]   [Full Text] [Related]  

  • 47. [The HLA system and atopy. Systematic and familial study in an asthmatic population (proceedings)].
    Perrin-Fayolle M; Betuel H; Biot N; Grosclaude M
    Acta Allergol; 1977 Jun; 32(3):222. PubMed ID: 578358
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased susceptibility to endocrine opthalmopathy in HLA CW3 positive thyrotoxicosis patients [proceedings].
    Ludwig H; Schernthaner G; Mayr WR; Mehdi SQ
    Diabete Metab; 1976 Sep; 2(3):163. PubMed ID: 1010142
    [No Abstract]   [Full Text] [Related]  

  • 49. [HLA and thyroid carcinoma (author's transl)].
    Feix C; Májský A; Nĕmec J
    Sb Lek; 1979 Jan; 81(1):19-22. PubMed ID: 424679
    [No Abstract]   [Full Text] [Related]  

  • 50. HLA antigen associated immuneresponsiveness to insulin in insulin dependent diabetes mellitus [proceedings].
    Bertrams J; Jansen FK; Grüneklee D; Reis HE; Drost H; Beyer J; Gries FA; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):309-13. PubMed ID: 1007381
    [No Abstract]   [Full Text] [Related]  

  • 51. [Distribution of the HLA antigen system in melanoblastoma of the uvea].
    Ignatov RK; Terent'eva LS; Shul'gina NS
    Oftalmol Zh; 1977; 32(4):289-94. PubMed ID: 896116
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of relapse in Graves' disease.
    Dahlberg PA; Holmlund G; Karlsson FA; Safwenberg J
    Lancet; 1980 Nov; 2(8204):1144. PubMed ID: 6107760
    [No Abstract]   [Full Text] [Related]  

  • 53. Proceedings: The structure of products of the major histocompatibility complex.
    Strominger JL
    Hoppe Seylers Z Physiol Chem; 1976 May; 357(5):620-1. PubMed ID: 964923
    [No Abstract]   [Full Text] [Related]  

  • 54. HLA differences between insulin dependent diabetics and non diabetic low insulin responders [proceedings].
    Vialettes B; Vague P; Mercier P
    Diabete Metab; 1976 Sep; 2(3):162. PubMed ID: 1010140
    [No Abstract]   [Full Text] [Related]  

  • 55. HLA-BW35 and B5 in Japanese patients with Graves' disease.
    Kawa A; Nakamura S; Nakazawa M; Sakaguchi S; Kawabata T; Maeda Y; Kanehisa T
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):754-7. PubMed ID: 579034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A negative association of HLA-BW52 with Graves' disease and insulin-dependent diabetes mellitus with juvenile onset among Japanese population.
    Kawa A; Nakamura S; Kono Y; Maeda Y; Kanehisa T
    Experientia; 1979 Apr; 35(4):547-8. PubMed ID: 582031
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA antigens in Europeans and Maoris.
    Filice GA; Wingo PA
    J Rheumatol; 1976 Dec; 3(4):437. PubMed ID: 1022875
    [No Abstract]   [Full Text] [Related]  

  • 58. [HL-A system and Graves' disease. Predominance of the DRW3 antigen].
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    Rev Med Interne; 1980; 1(2):163-70. PubMed ID: 6894803
    [No Abstract]   [Full Text] [Related]  

  • 59. [Temporary loss of HLA antigens in a healthy woman in connection with the menstrual cycle].
    Májský A; Jakoubková J
    Cas Lek Cesk; 1976 Sep; 115(36):1118. PubMed ID: 975189
    [No Abstract]   [Full Text] [Related]  

  • 60. HLA antigens and diffuse toxic goiter in Taiwan.
    Chen FW; Chen YC; Deng JS; Chen TS; Chen GH
    Taiwan Yi Xue Hui Za Zhi; 1978 Jan; 77(1):77-83. PubMed ID: 274517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.